Exploring Alzheimer's disease differences in Hispanic communities.
Understanding Alzheimer disease heterogeneity in Hispanic populations.
This study is looking at how genetics and social factors affect the start and progression of Alzheimer's disease in Hispanic communities, so we can better understand how these unique backgrounds influence the condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10895411 on NIH RePORTER |
What this research studies
This research investigates how genetic and social factors influence the onset and progression of Alzheimer's disease in Hispanic populations. It aims to analyze biomarkers and disease trajectories by utilizing large cohort studies and advanced statistical methods. The project is led by Dr. Jorge Libre under the mentorship of Dr. Randall J. Bateman, focusing on enhancing understanding of Alzheimer's disease specifically within Hispanic communities. Patients may contribute to a better understanding of how their unique backgrounds affect Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic individuals who may be at risk for Alzheimer's disease or related dementias.
Not a fit: Patients who do not identify as Hispanic or do not have a family history of Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to tailored prevention and treatment strategies for Alzheimer's disease in Hispanic populations.
How similar studies have performed: Previous research has shown success in understanding Alzheimer's disease through genetic and social factors, but this specific focus on Hispanic populations is relatively novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Llibre-Guerra, Jorge Jesus — Washington University
- Study coordinator: Llibre-Guerra, Jorge Jesus
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.